Late on Tuesday, the U.S. Medicare health plan announced newly negotiated prices for 15 of its costliest drugs which will go ...

Presenter: Audrey Gabelle, MD, PhD, Professor of Neurology, Neurologist and Member of the Anavex Scientific Advisory Board and Doctor in Neurosciences at the Memory Resources Research Center, the Rare ...

Here's how to distinguish "sundowning"—agitation or confusion later in the day in dementia patients—from typical aging, from doctors who treat older adults.

Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...

With dementia now estimated to impact 42 percent of people who make it past age 55, everyone should be taking steps to help ...

TUESDAY, Nov. 25, 2025 (HealthDay News) — A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer’s disease, drugmaker Novo Nordisk announced Monday ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Novo Nordisk’s closely-watched Alzheimer’s trials of an older oral version of its semaglutide drug failed to help slow the ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

Professor Baljit Khakh, a global authority on astrocytes and brain function, has been appointed Director of the UK Dementia Research Institute (UK DRI) at Cardiff University.

A renowned neuroscientist is returning to Cardiff to head-up one of the UK's leading centres for dementia research.Professor ...

What is reminiscence therapy? It's the approach Chris Hemsworth is using to fight his father's Alzheimer's disease in his new ...